These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2527286)

  • 81. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
    Alaupovic P; Knight-Gibson C; Wang CS; Downs D; Koren E; Brewer HB; Gregg RE
    J Lipid Res; 1991 Jan; 32(1):9-19. PubMed ID: 1901345
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene.
    Drayna DT; Hegele RA; Hass PE; Emi M; Wu LL; Eaton DL; Lawn RM; Williams RR; White RL; Lalouel JM
    Genomics; 1988 Oct; 3(3):230-6. PubMed ID: 2976021
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
    Chan DC; Watts GF; Coll B; Wasserman SM; Marcovina SM; Barrett PHR
    J Am Heart Assoc; 2019 Apr; 8(7):e011781. PubMed ID: 30897995
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Study of lipoprotein (a) phenotypes in Ivorian subject].
    Tiahou G; Aveynier E; Djessou P; Sess D; Cristol JP
    Bull Soc Pathol Exot; 2005 Jun; 98(2):99-103. PubMed ID: 16050374
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Quantitation of apolipoprotein B-48 in triacylglycerol-rich lipoproteins by a specific enzyme-linked immunosorbent assay.
    Lovegrove JA; Isherwood SG; Jackson KG; Williams CM; Gould BJ
    Biochim Biophys Acta; 1996 Jun; 1301(3):221-9. PubMed ID: 8664332
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with hyperthyroidism.
    Klausen IC; Hegedüs L; Hansen PS; Nielsen FE; Gerdes LU; Faergeman O
    J Mol Med (Berl); 1995 Jan; 73(1):41-6. PubMed ID: 7633941
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Protein composition of Lp(a) lipoprotein from human plasma.
    Utermann G; Weber W
    FEBS Lett; 1983 Apr; 154(2):357-61. PubMed ID: 6219896
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.
    Nowak-Göttl U; Junker R; Hartmeier M; Koch HG; Münchow N; Assmann G; von Eckardstein A
    Circulation; 1999 Aug; 100(7):743-8. PubMed ID: 10449697
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chimpanzee lipoprotein(A): Relationship between apolipoprotein(A) isoform size and the density profile of lipoprotein(A) in animals with different heterozygous apo(A) phenotypes.
    Doucet C; Wickings J; Chapman J; Thillet J
    J Med Primatol; 1998 Feb; 27(1):21-7. PubMed ID: 9606039
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma.
    Reblin T; Rader DJ; Beisiegel U; Greten H; Brewer HB
    Atherosclerosis; 1992 Jun; 94(2-3):223-32. PubMed ID: 1385958
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Apolipoprotein (a) alleles determine lipoprotein (a) particle density and concentration in plasma.
    Kraft HG; Sandholzer C; Menzel HJ; Utermann G
    Arterioscler Thromb; 1992 Mar; 12(3):302-6. PubMed ID: 1532126
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The effect of different apo(a) isoforms on plasminogen activation in black South African subjects.
    Choma SR; Alberts M; Potgieter HC; Ojwang PJ
    Cardiovasc J S Afr; 2003; 14(3):120-4. PubMed ID: 12844195
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard.
    Kostner GM; Ibovnik A; Holzer H; Grillhofer H
    J Lipid Res; 1999 Dec; 40(12):2255-63. PubMed ID: 10588951
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The ins and outs of lipoprotein(a) assay methods.
    Heydari M; Rezayi M; Ruscica M; Jpamialahamdi T; Johnston TP; Sahebkar A
    Arch Med Sci Atheroscler Dis; 2023; 8():e128-e139. PubMed ID: 38283929
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin.
    Edelstein C; Philips B; Pfaffinger D; Scanu AM
    FASEB J; 2009 Mar; 23(3):950-6. PubMed ID: 19001055
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample.
    Weiss LA; Abney M; Parry R; Scanu AM; Cook EH; Ober C
    Hum Genet; 2005 Jun; 117(1):81-7. PubMed ID: 15834589
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Successful utilization of lyophilized lipoprotein(a) as a biological reagent.
    Scanu AM; Hinman J; Pfaffinger D; Edelstein C
    Lipids; 2004 Jun; 39(6):589-93. PubMed ID: 15554160
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels.
    Scanu AM; Hinman J
    Lipids; 2002 May; 37(5):439-44. PubMed ID: 12056584
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The genetic dissection of complex traits in a founder population.
    Ober C; Abney M; McPeek MS
    Am J Hum Genet; 2001 Nov; 69(5):1068-79. PubMed ID: 11590547
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events.
    Scanu AM
    Curr Cardiol Rep; 2001 Sep; 3(5):385-90. PubMed ID: 11504575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.